Sequenom Inc. to Webcast Analyst and Investor Briefing Presentation on September 24

SAN DIEGO, Sept. 21 /PRNewswire-FirstCall/ -- Sequenom, Inc. today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event “Sequenom Today and Tomorrow.” Details of the event are as follows:

(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) What: Sequenom Today and Tomorrow When: Monday, September 24, 2007 at 4:15 p.m. Eastern time Where: http://www.sequenom.com How: Live over the Internet -- Simply log on to the web at the address above. Contact: Lippert/Heilshorn & Associates Jody Cain (jcain@lhai.com) 310-691-7100

Sequenom is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, livestock and agricultural applications, molecular medicine, and non-invasive prenatal testing. The Company’s proprietary MassARRAY(R) system is a high- performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY system and other platforms.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comSequenom, Inc.

CONTACT: Jody Cain of Lippert-Heilshorn & Associates, +1-310-691-7100,jcain@lhai.com, for Sequenom, Inc.

MORE ON THIS TOPIC